Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer cells are the primary target for oncolytic therapies, particularly oncolytic viruses (OVs). Oncolysis refers to the process by which these viruses selectively infect and destroy cancer cells while sparing normal, healthy tissue. This selectivity is due to unique features of cancer cells, such as defects in antiviral response pathways and altered oncogenic signaling that make them more susceptible to viral infection and replication.
Direct lysis & induction/augmentation of host antitumor immunity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer Cell (Oncolysis).